White blood cell count could predict severity of COVID-19 symptoms, reveals research Dr. Kamal Kant Kohli3 Feb 2025 9:15 AM ISTThanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however,...
FDA Approves Suzetrigine, a First-in-Class Non-Opioid Painkiller Dr. Kamal Kant Kohli3 Feb 2025 9:00 AM ISTThe US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, for the treatment...
Study Reveals Protective Properties of Amniotic Fluid Dr. Bhumika Maikhuri3 Feb 2025 8:45 AM ISTA new study, published in the journal Research and Practice in Thrombosis and Haemostasis. found that the addition of amniotic fluid to...
Indian Researchers Demonstrate Accelerated Healing with Platelet-Rich Fibrin in Open Tibial Fractures Medha Baranwal3 Feb 2025 8:00 AM ISTIndia: A recent randomized comparative pilot study, published online in Apollo Medicine has highlighted the potential of platelet-rich fibrin (PRF) in...
Proteinuria Linked to Increased Risk of Atrial Fibrillation Across All Glycemic Stages: Study Finds Medha Baranwal3 Feb 2025 8:00 AM ISTSouth Korea: A recent nationwide population-based cohort study has shed light on the significant relationship between proteinuria and the risk of...
Laryngopharyngeal Reflux Linked to Increased Risk of Tongue Base Obstruction in Nonobese Sleep Apnea Patients: Study Medha Baranwal2 Feb 2025 8:45 PM ISTTurkey: A recent study published in The Laryngoscope revealed a significant relationship between laryngopharyngeal reflux (LPR) and upper airway...
FDA Approves Symbravo for Acute Migraine Treatment Dr. Kamal Kant Kohli2 Feb 2025 8:30 PM ISTThe US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the treatment of acute migraine...
Sanofi Sarclisa approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Ruchika Sharma2 Feb 2025 10:45 AM ISTParis: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a...
New Dietary Recommendation for Managing Gastrointestinal Issues Treated with GLP-1 Receptor Agonists Dr Jeegar Dattani1 Feb 2025 4:51 PM ISTA recent commentary article published in Diabetes, Metabolic Syndrome and Obesity provides dietary recommendations for individuals using GLP-1...
Oral Semaglutide Lowers Cravings and Improves Metabolic Health in Type 2 Diabetes Patients: Study Dr Riya Dave1 Feb 2025 9:15 AM ISTA new study published in the journal Diabetes & Vascular Disease Research has found that oral semaglutide reduces total energy intake and changes...
Lerodalcibep Matches Evolocumab in LDL-C Reduction for HoFH: Lancet Dr. Shravani Dali1 Feb 2025 8:45 AM ISTResearchers have found in Phase 3 LIBerate-HoFH trial that Lerodalcibep, a third-generation PCSK9 inhibitor, showed similar efficacy to evolocumab in...
Cochrane Review Shows Antidepressants Reduce Anxiety, But Long-Term Effects Remain Unclear Dr. Bhumika Maikhuri1 Feb 2025 8:30 AM ISTA new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although...
